Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2387]

Patient-derived organoids help predict how patients respond to chemotherapy

Patient-derived organoids help predict how patients respond to chemotherapy

Organoid technology and single-cell sequencing to advance in the study of bladder cancer

Organoid technology and single-cell sequencing to advance in the study of bladder cancer

Large-scale mapping of protein networks behind tumor growth in the lungs

Large-scale mapping of protein networks behind tumor growth in the lungs

ESMO 2019: Targeted therapy slows progression of advanced prostate cancer

ESMO 2019: Targeted therapy slows progression of advanced prostate cancer

ESMO 2019: Two immunotherapy drug combination offers chemotherapy-free option for advanced NSCLC

ESMO 2019: Two immunotherapy drug combination offers chemotherapy-free option for advanced NSCLC

ESMO 2019: One in two patients with metastatic melanoma alive after five years with combination immunotherapy

ESMO 2019: One in two patients with metastatic melanoma alive after five years with combination immunotherapy

ESMO 2019: Patients with nmCRPC treated with apalutamide show 25 percent reduction in risk of death

ESMO 2019: Patients with nmCRPC treated with apalutamide show 25 percent reduction in risk of death

ESMO 2019: Men with prostate cancer can be spared radiotherapy after surgery

ESMO 2019: Men with prostate cancer can be spared radiotherapy after surgery

Discovery could improve MDS cancer treatment

Discovery could improve MDS cancer treatment

Resistance to immune checkpoint blocker drug linked to metabolic imbalance

Resistance to immune checkpoint blocker drug linked to metabolic imbalance

More from ecancer